Metabolite Findings in Tumefactive Demyelinating Lesions Utilizing Short Echo Time Proton Magnetic Resonance Spectroscopy

References

1. ↵
   Capello E, Roccatagliata L, Pagano F, et al. Tumor-like multiple sclerosis (MS) lesions: neuropathological clues. Neurol Sci 2001;22(suppl 2):113–16
2. ↵
   Saindane AM, Cha S, Law M, et al. Proton MR spectroscopy of tumefactive demyelinating lesions. AJNR Am J Neuroradiol 2002;23:1378–86

   Abstract/FREE Full Text
3. ↵
   Tan HM, Chan LL, Chuah KL, et al. Monophasic, solitary tumefactive demyelinating lesion: neuroimaging features and neuropathological diagnosis. Br J Radiol 2004;77:153–56

   Abstract/FREE Full Text
4. ↵
   Bitsch A, Bruhn H, Vougioukas V, et al. Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy. AJNR Am J Neuroradiol 1999;20:1619–27

   Abstract/FREE Full Text
5. ↵
   Law M, Meltzer DE, Cha S. Spectroscopic magnetic resonance imaging of a tumefactive demyelinating lesion. Neuroradiology 2002;44:986–89

   CrossRefPubMedWeb of Science
6. ↵
   Hsu YY, Chang C, Chang CN, et al. Proton MR spectroscopy in patients with complex partial seizures: single-voxel spectroscopy versus chemical-shift imaging. AJNR Am J Neuroradiol 1999;20:643–51

   Abstract/FREE Full Text
7. ↵
   Danielsen ER, Ross B. Basic physics of MRS. In: Magnetic Resonance Spectroscopy Diagnosis of Neurological Diseases. New York: Marcel Dekker;1999;5–22
8. ↵
   Lassman H. Comparative Neuropathology of Chronic Experimental Allergic Encephalomyelitis and Multiple Sclerosis. Berlin, Heidelberg: Springer-Verlag;1983
9. ↵
   Prineas JW. The neuropathology of multiple sclerosis. In: Koestsier JC, ed. Demyelinating Diseases. Amsterdam: Elsevier Science Publishers;1985;8:213–57
10. ↵
    Nesbit GM, Forbes GS, Scheithauer BW, et al. Multiple sclerosis: histopathologic and MR and/or CT correlation in 37 cases at biopsy and three cases at autopsy. Radiology 1991;180:467–74

    PubMedWeb of Science
11. ↵
    Mastrostefano R, Occhipinti E, Bigotti G, et al. Multiple sclerosis plaque simulating cerebral tumor: case report and review of the literature. Neurosurgery 1987;21:244–46

    PubMedWeb of Science
12. Hunter SB, Ballinger WE Jr, Rubin JJ. Multiple sclerosis mimicking primary brain tumor. Arch Pathol Lab Med 1987;111:464–68

    PubMedWeb of Science
13. Giang DW, Poduri KR, Eskin TA, et al. Multiple sclerosis masquerading as a mass lesion. Neuroradiology 1992;34:150–54

    CrossRefPubMedWeb of Science
14. Silva HC, Callegaro D, Marchiori PE, et al. Magnetic resonance imaging in five patients with a tumefactive demyelinating lesion in the central nervous system. Arq Neuropsiquiatr 1999;57:921–26

    CrossRefPubMed
15. Kalyan-Raman UP, Garwacki DJ, Elwood PW. Demyelinating disease of corpus callosum presenting as glioma on magnetic resonance scan: a case documented with pathological findings. Neurosurgery 1987;21:247–50

    PubMedWeb of Science
16. ↵
    Dagher AP, Smirniotopoulos J. Tumefactive demyelinating lesions. Neuroradiology 1996;38:560–65

    CrossRefPubMedWeb of Science
17. ↵
    Ott D, Hennig J, Ernst T. Human brain tumors: assessment with in vivo proton MR spectroscopy. Radiology 1993;186:745–52

    PubMedWeb of Science
18. ↵
    Fulham MJ, Bizzi A, Dietz MJ, et al. Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance. Radiology 1992;185:675–86

    PubMed
19. ↵
    Trapp BD, Peterson J, Ransohoff RM, et al. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998;338:278–85

    CrossRefPubMedWeb of Science
20. ↵
    Arnold DL, Matthews PM, Francis GS, et al. Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques. Ann Neurol 1992;31:435–41
21. Davie CA, Hawkins CP, Barker GJ, et al. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain 1994;117:49–58

    Abstract/FREE Full Text
22. ↵
    Silver NC, Barker RA, MacManus DG, et al. Proton magnetic resonance spectroscopy in a pathologically confirmed acute demyelinating lesion. J Neurol 1997;244:204–07

    CrossRefPubMedWeb of Science
23. ↵
    Chen CJ. Serial proton magnetic resonance spectroscopy in lesions of Balo concentric sclerosis. J Comput Assist Tomogr 2001;25:713–18

    CrossRefPubMedWeb of Science
24. ↵
    Bruhn H, Frahm J, Merboldt KD, et al. Multiple sclerosis in children: cerebral metabolic alterations monitored by localized proton magnetic resonance spectroscopy in vivo. Ann Neurol 1992;32:140–50

    CrossRefPubMedWeb of Science
25. ↵
    Simone IL, Tortorella C, Federico F, et al. Axonal damage in multiple sclerosis plaques: a combined magnetic resonance imaging and 1H-magnetic resonance spectroscopy study. J Neurol Sci 2001;182:143–50

    CrossRefPubMed
26. ↵
    Lopez-Villegas D, Lenkinski RE, Wehrli SL, et al. Lactate production by human monocytes/macrophages determined by proton MR spectroscopy. Magn Res Med 1995;34:32–38

    PubMed
27. ↵
    Krouwer HGJ, Kim TA, Rand SD, et al. Single voxel proton MR spectroscopy of nonneoplastic brain lesions suggestive of a neoplasm. AJNR Am J Neuroradiol 1998;19:1695–703

    Abstract
28. ↵
    Grossman RI, Lenkinski RE, Ramer KN, et al. MR proton spectroscopy in multiple sclerosis. AJNR Am J Neuroradiol 1992;13:1535–43

    Abstract/FREE Full Text
29. ↵
    Majos C, Julia-Sape M, Alonso J, et al. Brain tumor classification by proton MR spectroscopy: comparison of diagnostic accuracy at short and long TE. AJNR Am J Neuroradiol 2004;25:1696–704

    Abstract/FREE Full Text
30. ↵
    Danielsen ER, Ross B. The clinical significance of metabolites. In: Magnetic Resonance Spectroscopy Diagnosis of Neurological Diseases. New York: Marcel Dekker;1999;23–43
31. ↵
    Bartha R, Williamson PC, Drost DJ, et al. Measurement of glutamate and glutamine in the medial prefrontal cortex of never-treated schizophrenic patients and healthy controls by proton magnetic resonance spectroscopy. Arch Gen Psychiatry 1997;54:959–65

    CrossRefPubMedWeb of Science
32. ↵
    Schubert F, Gallinat J, Seifert F, et al. Glutamate concentrations in human brain using single voxel proton magnetic resonance spectroscopy at 3 Tesla. Neuroimage 2004;21:1762–71

    CrossRefPubMedWeb of Science